Topic: point-of-care diagnostics
GNA Biosolutions raised $13.5 million to support its point-of-care diagnostic platform designed to quickly examine different genomic samples.
Raj Krishnan discusses building Biological Dynamics, isolation methods for diagnostic testing and more.
Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.
HemoSonics’ point-of-care diagnostic for a patient’s coagulation status works within 15 minutes, to respond to critical bleeding situations.
Mammoth Biosciences is harnessing CRISPR to create diagnostic tools that can detect any biomarker containing DNA or RNA. It just added Cas14 to its arsenal.
Danaher’s point-of-care focused HemoCue subsidiary has launched its newest hemoglobin test in the U.S. following a recent 510(k) clearance.
Sight Diagnostics, maker of point-of-care blood diagnostic hardware, raised $27.8 million to continue its expansion and fund U.S. regulatory efforts.
Ceribell raised $35 million for its rapid-response EEG headband that quickly diagnoses patients suspected of having seizures with no visual symptoms.
MeMed raised $70 million for its immune system diagnostic for distinguishing between bacterial and viral infections, to reduce antibiotic misuse.
Diagnostic maker Echosens is teaming up with a consortium of health systems to develop a real-world evidence model to help standardize care for NASH.